Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 11INDUSTRY 7NIH 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Ovarian Neoplasms 117Uterine Cervical Neoplasms 65Carcinoma, Ovarian Epithelial 64Fallopian Tube Neoplasms 62Endometrial Neoplasms 38Brenner Tumor 22Sarcoma 18Testicular Neoplasms 15Vulvar Neoplasms 12Squamous Intraepithelial Lesions 10Sarcoma, Endometrial Stromal 10Endometrial Adenocarcinoma 10Breast Neoplasms 10Ovarian Germ Cell Cancer 9HIV Infections 9Teratoma 7Sarcoma, Synovial 7Precancerous Conditions 7Osteosarcoma 7Neurofibrosarcoma 7Neuroblastoma 7Melanoma 7Liposarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Carcinoma, Non-Small-Cell Lung 7Uterine Cervical Dysplasia 6Stomach Neoplasms 6

Interventions

Taxes 1Paclitaxel 1Ifosfamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinosarcoma × Gynecologic × Clear all
NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡